Skip to main content
SpringerLink
Log in

Oral Contraceptives and Lipid Metabolism

  • Conference paper
Female Contraception

Abstract

The most important causes of higher mortality in users of oral contraceptives (OC) due to cardiovascular diseases such as thromboembolic insults, myocardial infarction and cerebral insults are related to changes in metabolism: changes in lipid metabolism with development of atherosclerosis, changes in carbohydrate metabolism with development of a chemical diabetes mellitus, and deterioration of the renin-angiotensin-aldosterone system leading to hypertension, changes in blood coagulation, fibrinolysis and morphological changes of blood vessels. These changes are caused predominantly by environmental factors (e. g., nutrition, physical activity, and standard of living) and less by genetic factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson FD (1985) Review of open phase-Ill clinical data on Cilest 250/35. Paper read at the XIth world congress of gynecology and obstretics, Berlin (West), September 15–20, 1985

    Google Scholar 

  • Assmann G (1987) Oral contraceptives and lipids. 2nd International symposium: new aspects in female contraception - update and trends

    Google Scholar 

  • Assmann G, Schettler G (1987) Die Prävention der koronaren Herzkrankheit. Deutsches Ärzteblatt - Ärztliche Mitteilungen 9:45–48

    Google Scholar 

  • Assmann G, Schulte H (1986) Procam-Studie. Panscientia, Hedingen, Zürich

    Google Scholar 

  • Assmann G, Schriewer H, Juchem KH (1981) Zur Rolle des HDL-Cholesterin bei der Präventivmedizin. Therapiewoche 31:5563–5574

    CAS  Google Scholar 

  • Barr DP (1953) Some chemical factors in the pathogenesis of atherosclerosis. Circulation 8:641–654

    PubMed  CAS  Google Scholar 

  • Barr DP (1955) Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma. J Chronic Dis 1:63–85

    Article  PubMed  CAS  Google Scholar 

  • Bradley DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S (1978) Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 299:17–20

    Article  PubMed  CAS  Google Scholar 

  • Carlson LA, Böttiger LE (1972) Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet 1:865–868

    Article  PubMed  CAS  Google Scholar 

  • Gaspard UJ, Romus MA, Gillain D (1984 a) Comparative study of lipid metabolism and endocrine function in women receiving levonorgestrel- and desogestrel-containing oral contraceptives. In: Harrison RF, Bonnar J, Thompson (eds) Advances in fertility control and the treatment of sterility. MTP, Lancaster, pp 81–87

    Google Scholar 

  • Gaspard UJ, Romus MA, Luyckx AS (1984 b) Carbohydrate metabolism alterations with monophasic, sequential and triphasic oral contraceptives containing ethinyloestradiol plus levonorgestrel or desogestrel. In: Harrison RF, Bonnar J, Thompson (eds) Advances in fertility control and the treatment of sterility. MTP, Lancaster pp 107–111

    Google Scholar 

  • Gaspard UJ, Lepot MR, Jaminet C, Jandrain B, Lefebvre PJ (1986 a) Carbohydrate metabolism in women receiving two low-dose triphasic oral contraceptives, triquilar and trigestoden for one year. World congress of sterility and fertility, Singapur 1986, abstract, p 422

    Google Scholar 

  • Gaspard UJ, Lepot MR, Gillain D, Sulon J, Buret J (1986 b) Lipoprotein metabolism and carrier protein levels in women using two low-dose triphasic oral contraceptives (OCs), triquilar and trigestoden for one year. World congress of sterility and fertility, Singapur 1986, abstract, p 423

    Google Scholar 

  • Glueck CJ, Fallat RW, Scheel D (1975) Effects of estrogenic compounds on triglyceride kinetics. Metabolism 24:537–545

    Article  PubMed  CAS  Google Scholar 

  • Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62:707–714

    Article  PubMed  CAS  Google Scholar 

  • Grundy SM (1984) AHA special report: recommendations for the treatment of hyperlipidemia in adults. Atherosclerosis 4:445A-465A

    Google Scholar 

  • Hopkins PN, Williams RR (1981) A survey of 246 suggested coronary risk factors. Ath- erosklerosis 40:1–52

    CAS  Google Scholar 

  • Kaiser E, Panitz N, Groth (1985) Influence of eilest 250/35 on carbohydrate and lipid metabolism. XI World Congress on Obstetrics and Gynecology (unpublished data)

    Google Scholar 

  • Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of atherosclerotic disease. Ann Intern Med 90:85–91

    PubMed  CAS  Google Scholar 

  • Kohlmeier M, Rabe T, Runnebaum B, Schlierf G (1984) Orale Kontrazeption und Lipid- stoffwechsel. In: Runnebaum B, Rabe T (eds) Hormonale Kontrazeption. Steinkopff, Darmstadt, pp 58–62

    Google Scholar 

  • Kühl H (1986) Effekt von zwei oralen Kontrazeptiva mit abweichendem Gestagenanteil auf die Lipoproteinserumspiegel. In: Informed Institut für Medizinische Kommunikation (ed) 6. Internationales Gespräch, Münster/München 1986, Satelliten-Symposium: Hormonale Kontrazeption und Herzkreislauf pp 36–42

    Google Scholar 

  • Lewis B (1983) The lipoproteins: predictors, protectors, pathogens. Br Med J [Clin Res] 287:1161–1164

    Article  CAS  Google Scholar 

  • Lipid Research Clinics Program (1984 a) The lipid research clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. JAMA 251:351–364

    Article  Google Scholar 

  • Lipid Research Clinics Program (1984 b) The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365–374

    Article  Google Scholar 

  • Maciejko J, Holmes D, Kottke B, Zinsmeister A, Dinh D, Mao S (1983) Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 309:385–89

    Article  PubMed  CAS  Google Scholar 

  • März W, Romberg G, Gahn G, Gross W, Kühl H, Taubert H-D (1984) Effect of oral contraceptives upon serum lipoprotein pattern in healthy women. In: Rolland R (ed) Advances in fertility control and the treatment of sterility. MTP, Lancaster, pp 99–105

    Google Scholar 

  • März W, Gross W, Gahn G, Romberg G, Taubert H-D, Kühl H (1985) A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 153:287–293

    PubMed  Google Scholar 

  • Miller NE, Thelle DS, Forde OH, Mjos OD (1977) The tromsö-heart study: high-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1:965–967

    Article  PubMed  CAS  Google Scholar 

  • Miller NE, Hammett F, Saltissi S, Rao S, van Zeller H, Coltart Y, Lewis B (1981) Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J [Clin Res] 282:1741–1744

    Article  CAS  Google Scholar 

  • Rabe T, Runnebaum B (1986 a) Progestins and carbohydrate metabolism. Int J Fertil [Suppl]:31–45

    Google Scholar 

  • Rabe T, Runnebaum B (1986 b) Arzneimittelprüfung von oralen Kontrazeptiva heute. In: Hammerstein J (ed) 25 Jahre hormonale Kontrazeptiva aus Berlin. Excerpta Medica, Amsterdam, pp 62–72

    Google Scholar 

  • Rabe T, Grunwald K, Runnebaum B (1988 a) Einfluß oraler hormonaler Kontrazeptiva auf den Lipidstoffwechsel; Teil 1: Lipidstoffwechsel, Cholesterin und Triglyzeride. Fertilität 4:35–51

    CAS  Google Scholar 

  • Rabe T, Grunwald K, Runnebaum B (1988 b) Einfluß oraler hormonaler Kontrazeptiva auf den Lipidstoffwechsel; Teil 2: Lipoproteine, Apoproteine. Fertilität (to be published)

    Google Scholar 

  • Rabe T, Grunwald K, Runnebaum B (1988 c) Pille und Kohlenhydratstoffwechsel. Fertilität 4:97–111

    CAS  Google Scholar 

  • Rabe T, Runnebaum B, Weicker H (1984) Kohlenhydrat- und Androgenstoffwechsel unter oraler Kontrazeption mit einer norethisteronhaltigen Dreistufenpille (TriNovum). In: Runnebaum B, Rabe T (eds) Hormonale Kontrazeption. Steinkopff, Darmstadt, pp 40–57

    Google Scholar 

  • Rabe T, Runnebaum B, Kohlmeyer M, Weicker H (1986) Lipid, carbohydrate, and androgen metabolism in women using a triphasic oral contraceptive containing norethin- drone for one year. Int J Fertil 31:46–52

    PubMed  Google Scholar 

  • Rabe T, Runnebaum B, Unger R, Kohlmeier M, Harenberg J, Weicker H (1987 a) Clinical and metabolic effects of two low dose combined pills for oral contraception containing gestodene (SHD 356C) or levonorgestrel (Microgynon). In: Genazzani AR, Volpe A, Facchinetti (eds) Research on gynecological endocrinology. Congress proceedings 1st World Congress of Gynecological Endocrinology, Madonna di Campiglio, Italien 1986, pp 503–516

    Google Scholar 

  • Rabe T, Runnebaum B, Kaiser E, Anger H (1987 b) Metabolic effects of a norgestimate containing low-dose pill (Cilest 250/35): on lipid and carbohydrate metabolism and blood clotting. In: Genazzani AR, Volpe A, Facchinetti (eds) Research on gynecological endocrinology. Congress proceedings 1st World Congress of Gynecological Endocrinology, Madonna di Campiglio, Italien 1986, pp 443–449

    Google Scholar 

  • Rabe T, Grunwald K, Kiesel L, Runnebaum B (1988 b) Einfluß einer levonorgestrelhaltigen Dreiphasenpille auf den Lipid- und Kohlenhydratstoffwechsel (to be published)

    Google Scholar 

  • Rhoads GG, Gulbrandsen CL, Kagan A (1976) Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 294:293–298

    Article  PubMed  CAS  Google Scholar 

  • Rifkind BM, Segal P (1983) Lipid research clinics programm reference values for hyperlip-idemia and hypolipidemia. JAMA 250:1869–1872

    Article  PubMed  CAS  Google Scholar 

  • Royal College of General Practitioners Oral Contraceptive Study (1981) Further analyses of mortality in oral contraceptive users. Lancet 1:541–546

    Google Scholar 

  • Schijf CPT, Thomas CMG, Demacker PNM, Doesburg WH, Rolland R (1984) The influence of the triphasic pill and a desogestrel-containing combination pill on some physical, biochemical and hormonal parameters: a preliminary report. In: Harrison RF, Bonnar J, Thompson (eds) Advances in fertility control and the treatment of sterility. MTP Press, Lancaster, pp 61–69

    Google Scholar 

  • Schweppe KW (1983) Erfahrung mit einem neuen Kontrazeptivum Marvelon unter besonderer Berücksichtigung des Fettstoffwechsels bei Raucherinnen und Nichtraucherinnen. In: Mall-Haefeli M (ed) Kongressband: Internationales Symposium des Sozialmedizinischen Dienstes der Univ. Frauenklinik Basel, 7./8. April 1983, Karger, Basel, pp 102–113

    Google Scholar 

  • Seidel D, Cremer P, Thiery J (1985) Plasmalipoproteine und Atherosklerose. II. Lipopro-teindiagnostik. Therapie der Fettstoffwechselstörungen. Int Welt 8:159–165

    Google Scholar 

  • Silferstolpe G, Gustafson A, Samsioe G, Svanborg A (1982) Lipid and carbohydrate metabolism studies in oophorectomized women: effects produced by the addition of norethisterone acetate to two estrogen preparations. Arch Gynecol 231:279–287

    Article  Google Scholar 

  • Stössel J-P (1980) Wie entsteht Arteriosklerose? Med Klin 75:2–12

    Google Scholar 

  • Wallace RB, Hoover J, Sandler D, Rifkind BM, Tyroler HA (1977) Altered plasma-lipids associated with oral contraceptive or oestrogen consumption. Lancet 11:11–14

    Article  Google Scholar 

  • Wynn V, Nithtyananthan R (1982) The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol 142:766–772

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology, Women’s Hospital, University of Heidelberg, Voßstr. 9, 6900, Heidelberg, Germany

    T. Rabe, K. Grunwald, L. Kiesel & B. Runnebaum

Authors
  1. T. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Grunwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Kiesel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Runnebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology, Women’s Hospital, University of Heidelberg, Voßstr. 9, D-6900, Heidelberg, Germany

    Benno Runnebaum , Thomas Rabe  & Ludwig Kiesel ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rabe, T., Grunwald, K., Kiesel, L., Runnebaum, B. (1988). Oral Contraceptives and Lipid Metabolism. In: Runnebaum, B., Rabe, T., Kiesel, L. (eds) Female Contraception. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73790-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73790-9_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73792-3

  • Online ISBN: 978-3-642-73790-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation